BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 14558439)

  • 21. "Indirect" acute islet allograft destruction in nonobese diabetic mice is independent of donor major histocompatibility complex and requires host B lymphocytes.
    Kupfer T; Beilke JN; Pham K; Buhrman J; Gill RG
    Transplant Proc; 2008 Mar; 40(2):462-3. PubMed ID: 18374102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinct requirements for host CD80/CD86 costimulatory molecules in cardiac versus islet rejection.
    Johnson Z; Beilke J; Pietra B; Kelly B; Gill RG
    Transplant Proc; 2004 May; 36(4):1171-2. PubMed ID: 15194405
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Islet allograft rejection is independent of toll-like receptor signaling in mice.
    Hutton MJ; Westwell-Roper C; Soukhatcheva G; Plesner A; Dutz JP; Verchere CB
    Transplantation; 2009 Nov; 88(9):1075-80. PubMed ID: 19898202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel immunosuppression: R348, a JAK3- and Syk-inhibitor attenuates acute cardiac allograft rejection.
    Deuse T; Velotta JB; Hoyt G; Govaert JA; Taylor V; Masuda E; Herlaar E; Park G; Carroll D; Pelletier MP; Robbins RC; Schrepfer S
    Transplantation; 2008 Mar; 85(6):885-92. PubMed ID: 18360272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pravastatin and low-dose cyclosporine treatment prevent islet allograft rejection in mice.
    Arita S; Kasraie A; Une S; Ohtsuka S; Atiya A; Shevlin L; Mullen Y
    Transplant Proc; 1998 Mar; 30(2):522. PubMed ID: 9532158
    [No Abstract]   [Full Text] [Related]  

  • 26. In vivo toxicity and pharmacokinetic features of the janus kinase 3 inhibitor WHI-P131 [4-(4'hydroxyphenyl)-amino-6,7- dimethoxyquinazoline.
    Uckun FM; Ek O; Liu XP; Chen CL
    Clin Cancer Res; 1999 Oct; 5(10):2954-62. PubMed ID: 10537365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The specificity of JAK3 kinase inhibitors.
    Changelian PS; Moshinsky D; Kuhn CF; Flanagan ME; Munchhof MJ; Harris TM; Whipple DA; Doty JL; Sun J; Kent CR; Magnuson KS; Perregaux DG; Sawyer PS; Kudlacz EM
    Blood; 2008 Feb; 111(4):2155-7. PubMed ID: 18094329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of transplant rejection by pretreatment of xenogeneic pancreatic islet cells with anti-ICAM-1 antibodies.
    Zeng Y; Gage A; Montag A; Rothlein R; Thistlethwaite JR; Bluestone JA
    Transplantation; 1994 Sep; 58(6):681-9. PubMed ID: 7940687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IL-12p40 is not required for islet allograft rejection.
    Bi EG; Shi W; Zou J; Hao ZH; Li ZH; Cai D; Zhang HQ; Sun B
    Acta Pharmacol Sin; 2006 Aug; 27(8):1065-70. PubMed ID: 16867260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic and biochemical evidence for a critical role of Janus kinase (JAK)-3 in mast cell-mediated type I hypersensitivity reactions.
    Malaviya R; Uckun FM
    Biochem Biophys Res Commun; 1999 Apr; 257(3):807-13. PubMed ID: 10208864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic allograft nephropathy is prevented by inhibition of platelet-derived growth factor receptor: tyrosine kinase inhibitors as a potential therapy.
    Savikko J; Taskinen E; Von Willebrand E
    Transplantation; 2003 Apr; 75(8):1147-53. PubMed ID: 12717194
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of intra-islet endothelial cells in islet allo-immunity.
    Bharat A; Saini D; Benshoff N; Goodman J; Desai NM; Chapman WC; Mohanakumar T
    Transplantation; 2007 Nov; 84(10):1316-23. PubMed ID: 18049117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detecting rejection after mouse Islet transplantation utilizing islet protein-stimulated ELISPOT.
    Toso C; Pawlick R; Lacotte S; Edgar R; Davis J; McCall M; Morel P; Mentha G; Berney T; Shapiro AM
    Cell Transplant; 2011; 20(6):955-62. PubMed ID: 21054945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein kinase C inhibitor, AEB-071, acts complementarily with cyclosporine to prevent islet rejection in rats.
    Merani S; Pawlick RL; Edgar RL; Toso C; Emamaullee J; Anderson CC; Shapiro AM
    Transplantation; 2009 Jan; 87(1):59-65. PubMed ID: 19136892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leflunomide and cyclosporin-A prolong fish-to-mouse islet xenograft survival in BALB/C mice.
    Wright JR; Kearns H; McDonald AS
    Transplant Proc; 1994 Jun; 26(3):1310. PubMed ID: 8029918
    [No Abstract]   [Full Text] [Related]  

  • 36. Induction of unresponsiveness to islet allograft by anti-LFA-1 monoclonal antibody treatment.
    Gotoh M; Fukuzaki T; Dono K; Wada H; Kanai T; Monden M; Yagita H; Okumura K; Mori T
    Transplant Proc; 1993 Feb; 25(1 Pt 2):973-4. PubMed ID: 8442286
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparison of successful and unsuccessful islet/Sertoli cell cotransplant grafts in streptozotocin-induced diabetic mice.
    Dufour JM; Lord SJ; Kin T; Rayat GR; Dixon DE; Bleackley RC; Korbutt GS; Rajotte RV
    Cell Transplant; 2008; 16(10):1029-38. PubMed ID: 18351019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitor.
    Changelian PS; Flanagan ME; Ball DJ; Kent CR; Magnuson KS; Martin WH; Rizzuti BJ; Sawyer PS; Perry BD; Brissette WH; McCurdy SP; Kudlacz EM; Conklyn MJ; Elliott EA; Koslov ER; Fisher MB; Strelevitz TJ; Yoon K; Whipple DA; Sun J; Munchhof MJ; Doty JL; Casavant JM; Blumenkopf TA; Hines M; Brown MF; Lillie BM; Subramanyam C; Shang-Poa C; Milici AJ; Beckius GE; Moyer JD; Su C; Woodworth TG; Gaweco AS; Beals CR; Littman BH; Fisher DA; Smith JF; Zagouras P; Magna HA; Saltarelli MJ; Johnson KS; Nelms LF; Des Etages SG; Hayes LS; Kawabata TT; Finco-Kent D; Baker DL; Larson M; Si MS; Paniagua R; Higgins J; Holm B; Reitz B; Zhou YJ; Morris RE; O'Shea JJ; Borie DC
    Science; 2003 Oct; 302(5646):875-8. PubMed ID: 14593182
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A420983, a novel, small molecule inhibitor of LCK prevents allograft rejection.
    Waegell W; Babineau M; Hart M; Dixon K; McRae B; Wallace C; Leach M; Ratnofsky S; Belanger A; Hirst G; Rossini A; Appel M; Mordes J; Greiner D; Banerjee S
    Transplant Proc; 2002 Aug; 34(5):1411-7. PubMed ID: 12176420
    [No Abstract]   [Full Text] [Related]  

  • 40. Targeting Janus kinase 3 in mast cells prevents immediate hypersensitivity reactions and anaphylaxis.
    Malaviya R; Zhu D; Dibirdik I; Uckun FM
    J Biol Chem; 1999 Sep; 274(38):27028-38. PubMed ID: 10480916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.